US2008009445A1PendingUtilityA1
Anti-endotoxic, antimicrobial cationic peptides, the encoding DNA and methods of use thereof
Est. expiryAug 28, 2018(expired)· nominal 20-yr term from priority
A61P 31/04A61K 31/711A61K 38/00C07K 14/4723Y02A50/30
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A novel class of cationic peptides having antimicrobial activity is provided. Exemplary peptides of the invention include KWKSFIKKLTSAAKKVVTTAKPLALIS (SEQ ID NO:3) and KGWGSFFKKAAHVGKHVGKAALTHYL (SEQ ID NO:15). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. Such methods are useful for the treatment of respiratory infections, such as in cystic fibrosis patients. Such methods are further useful for accelerating wound healing.
Claims
exact text as granted — not AI-modified1 . An isolated antimicrobial peptide having an amino acid sequence selected from the group consisting of:
KWKSFIKKLTSAAKKVVTTAKPLALIS;
(SEQ ID NO:3)
KWKSFIKKLTKAAKKVVTTAKKPLIV;
(SEQ ID NO:4)
KWKKFIKSLTKSAAKTVVKTAKKPLV;
(SEQ ID NO:5)
KWKLFKKIGIGAVLKVLKVLTTGLPALKLTLK;
(SEQ ID NO:6)
KLFKKIGIGAVLKVLKVLTTGLPALKLTLK;
(SEQ ID NO:7)
KWKFKKIGIGAVLKVLKVLTTGLPALKLTLK;
(SEQ ID NO:8)
KLWKLFKKIGIGAVLKVLKVLTTGLPALKLTLK;
(SEQ ID NO:9)
KWKSFIKKLTSAAKKVTTAAKPLTK;
(SEQ ID NO:10)
KWKKFIKKIGIGAVLKVLTTGLPALKLTKK;
(SEQ ID NO:11)
KKWKKFIKKIGIGAVLTTPGAKK;
(SEQ ID NO:12)
GWGSFFKKAAHVGKHVGKAALTHYL-NH2;
(SEQ ID NO:14)
KGWGSFFKKAAHVGKHVGKAALTHYL;
(SEQ ID NO:15)
KGWGSFFKKAAHVGKHVGKAALTHYL-NH2;
(SEQ ID NO:16)
ALWKTMLKKAAHVGKHVGKAALTHYL-NH2;
(SEQ ID NO:17)
SIGSAFKKAAHVGKHVGKAALTHYL-NH2;
(SEQ ID NO:18)
GWGSFFKKAAHVGKHVGKAALGAAARRRK;
(SEQ ID NO:19)
ALWKTMLKKAAHVGKHVGKAALGAAARRRK;
(SEQ ID NO:20)
and
SIGSAFKKAAHVGKHVGKAALGAAARRRK;
(SEQ ID NO:21)
and analogs, derivatives, amidated variations and conservative variations thereof.
2 . An isolated polynucleotide which encodes a peptide of claim 1 .
3 . An isolated polynucleotide which encodes a peptide selected from the group consisting of:
KWKSFIKKLTSAAKKVVTTAKPLALIS
(SEQ ID NO:3)
KWKSFIKKLTKAAKKVVTTAKKPLIV
(SEQ ID NO:4)
KWKKFIKSLTKSAAKTVVKTAKKPLIV
(SEQ ID NO:5)
KWKLFKKIGIGAVLKVLKVLTTGLPALKLTLK
(SEQ ID NO:6)
KLFKKIGIGAVLKVLKVLTTGLPALKLTLK
(SEQ ID NO:7)
KWKFKKIGIGAVLKVLKVLTTGLPALKLTLK
(SEQ ID NO:8)
KLWKLFKKIGIGAVLKVLKVLTTGLPALKLTLK
(SEQ ID NO:9)
KWKSFIKKLTSAAKKVTTAAKPLTK
(SEQ ID NO:10)
KWKKFIKKIGIGAVLKVLTTGLPALKLTKK
(SEQ ID NO:11)
KKWKKFIKKIGIGAVLTTPGAKK
(SEQ ID NO:12)
GWGSFFKKAAHVGKHVGKAALTHYL
(SEQ ID NO:14)
KGWGSFFKKAAHVGKHVGKAALTHYL
(SEQ ID NO:15)
ALWKTMLKKAAHVGKHVGKAALTHYL
(SEQ ID NO:17)
SIGSAFKKAAHVGKHVGKAALTHYL
(SEQ ID NO:18)
GWGSFFKKAAHVGKHVGKAALGAAARRRK
(SEQ ID NO:19)
ALWKTMLKKAAHVGKHVGKAALGAAARRRK;
(SEQ ID NO:20)
and
SIGSAFKKAAHVGKHVGKAALGAAARRRK.
(SEQ ID NO:21)
4 . A method of inhibiting the growth of bacteria comprising contacting the bacteria with an inhibiting effective amount of a peptide having an amino acid sequence selected from the group consisting of:
GWGSFFKKAAHVGKHVGKAALTHYL-NJ32;
(SEQ ID NO:14)
KGWGSFFKKAAHVGKHVGKAALTHYL;
(SEQ ID NO:15)
KGWGSFFKKAAHVGKHVGKAALTHYL-NH2;
(SEQ ID NO:16)
ALWKTMLKKAAHVGKHVGKAALTHYL-NH2;
(SEQ ID NO:17)
SIGSAFKKAAHVGKHVGKAALTHYL-NH2;
(SEQ ID NO:18)
GWGSFFKKAAHVGKHVGKAALGAAARRRK;
(SEQ ID NO:19)
ALWKTMLKKAAHVGKHVGKAALGAAARRRK;
(SEQ ID NO:20)
SIGSAFKKAAHVGKHVGKAALGAAARRRK;
(SEQ ID NO:21)
and analogs, derivatives, amidated variations and conservative variations thereof.
5 . An isolated polynucleotide which encodes a peptide of claim 4 .
6 . An isolated polynucleotide which encodes a peptide selected from the group consisting of:
GWGSFFKKAAHVGKHVGKAALTHYL-NH2;
(SEQ ID NO:14)
KGWGSFFKKAAHVGKHVGKAALTHYL;
(SEQ ID NO:15)
KGWGSFFKKAAHVGKHVGKALTHYL-NH2;
(SEQ ID NO:16)
ALWKTMLKKAAHVGKRVGKAALTHYL-NH2;
(SEQ ID NO:17)
SIGSAFKKAAHVGKHVGKAALTHYL-NH2;
(SEQ ID NO:18)
GWGSFFKKAAHVGKHVGKAALGAAARRRK;
(SEQ ID NO:19)
ALWKTMLKKAAHVGKHVGKAALGAAARRRK;
(SEQ ID NO:20)
SIGSAFKKAAHVGKHVGKAALGAAARRRK.
(SEQ ID NO:21)Join the waitlist — get patent alerts
Track US2008009445A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.